⌘K

Home/Filings/4/0001213900-22-037267

4//SEC Filing

Bandari Jathin 4

Accession 0001213900-22-037267

CIK 0001359931other

View on SEC.gov Company Profile

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 5:00 PM ET

Size

5.0 KB

Accession

0001213900-22-037267

Insider Transaction Report

Form 4

Period: 2022-07-01

Protara Therapeutics, Inc.TARA

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2022-07-01$3.22/sh−682$2,196→ 20,318 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on July 1, 2020.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1

filerCIK 0001903622

Filing Metadata

Form type: 4
Filed: Jul 4, 8:00 PM ET
Accepted: Jul 5, 5:00 PM ET
Size: 5.0 KB

View on SEC.gov